Financial Year |
March 31 2023 |
Monetary Funds |
3,865,472,995.94 |
Held-for-trading Financial Assets |
1,034,898,740.08 |
Notes Receivable |
52,640,227.63 |
Accounts Receivable |
1,265,055,527.64 |
Advances to Suppliers |
185,929,844.02 |
Other Receivables |
27,673,952.17 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
3,896,371,672.45 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
302,726,956.01 |
Total Current Assets |
11,104,201,276.54 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
9,699,600.74 |
Long-term Equity Investment |
138,241,837.99 |
Investment Properties |
17,678,738.20 |
Fixed Assetes |
832,461,194.10 |
Under-construction Projects |
328,928,183.30 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
282,391,763.77 |
R&D expenses |
-- |
Goodwill |
146,283,083.98 |
Long-Term Deferred and Prepaid Expenses |
33,759,820.09 |
Deferred Income Tax Assets |
128,197,253.05 |
Other Non-Current Assets |
92,920,368.17 |
Sub-Total of Non-Current Assets |
2,160,380,435.84 |
Total Assets |
13,264,581,712.38 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
914,976,337.51 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
71,007,640.41 |
Taxes Payable |
103,256,212.71 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
40,285,510.99 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,283,484.59 |
Other Current Liabilities |
159,484,913.90 |
Sub-Total of Current Liabilities |
5,222,192,085.18 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
23,451,351.36 |
Deferred Income Tax Liabilities |
35,989,524.10 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
140,650,862.80 |
Total Liabilities |
5,362,842,947.98 |
Paid-In Capital(Or Share Stock) |
755,523,040.00 |
Capital Surplus |
3,482,157,740.45 |
Surplus Reserve |
364,378,719.76 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
2,941,899,816.97 |
Minority Stockholder's Interest |
216,447,402.24 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,685,291,362.16 |
Owner's Equity(Stockholder's Equity) |
7,901,738,764.40 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
13,264,581,712.38 |